Dr. Amy SanguinettiMD, PhD

Internal Medicine

at Achieve Health NV — Reno, NV

About

Dr. Amy Sanguinetti earned her PhD in Biochemistry from the University of Nevada, Reno before completing her medical degree at the same institution. Her doctoral research examined cellular signaling pathways, insulin resistance, and oxidative stress in obesity and diabetes. That scientific foundation gives her an unusually precise understanding of the mechanisms behind metabolic disease. She completed her residency in Internal Medicine and holds board certifications in both Internal Medicine and Obesity Medicine, achieving her Obesity Medicine certification in 2020. She also holds Menopause Certification.

Dr. Sanguinetti focuses on preventive medicine, chronic disease management, and the intersection of metabolic health and hormonal transitions, including perimenopause and menopause. She applies evidence-based, personalized strategies to help patients reach their wellness goals. Deep roots in the Reno community shape her commitment to accessible, relationship-driven care. Outside the clinic, she enjoys cycling, running, and hiking throughout Northern Nevada. She shares her home with her husband, children, a grandson, and two devoted dogs.

Education & Training

Medical School

University of Nevada, Reno

Residency

Internal Medicine

Additional Training

PhD in Biochemistry, University of Nevada, Reno; research focused on insulin and oxidative stress pathways in obesity and diabetes

Certifications

Board Certified in Internal Medicine
Board Certified in Obesity Medicine (achieved 2020)

Conditions Treated

obesity
diabetes
metabolic disorders
chronic disease
weight-related illnesses
perimenopause
menopause

Who is Dr. Sanguinetti right for?

Dr. Sanguinetti is a strong fit for adults managing obesity, metabolic disorders, or diabetes who want a physician with deep scientific expertise in those conditions. Her background in biochemistry makes her especially effective with patients navigating complex chronic disease. Women experiencing perimenopause or menopause benefit from her dual clinical and hormonal focus. Patients who value a physician with long-standing ties to the Reno community will feel at home with her approach.

Similar Doctors Nearby

Frequently Asked Questions

Dr. Sanguinetti specializes in obesity, diabetes, metabolic disorders, and chronic disease. She also treats patients through perimenopause and menopause. Her PhD research in insulin and oxidative stress pathways gives her a deep clinical foundation in the metabolic conditions that drive many chronic illnesses.

Yes. Dr. Sanguinetti holds board certifications in both Internal Medicine and Obesity Medicine. She achieved her Obesity Medicine certification in 2020. She also carries Menopause Certification, reflecting her focus on hormonal health and the menopause transition.

Dr. Sanguinetti earned a PhD in Biochemistry and an MD, both from the University of Nevada, Reno. She then completed a residency in Internal Medicine. Her doctoral research focused specifically on insulin resistance and oxidative stress in obesity, giving her a research-level understanding of metabolic disease.

Dr. Sanguinetti takes an evidence-based, individualized approach to weight management. She combines medical treatment with nutrition counseling, exercise guidance, and body composition monitoring. She also manages GLP-1 medications such as semaglutide and tirzepatide when clinically appropriate.

Yes. Dr. Sanguinetti holds Menopause Certification and regularly treats patients navigating perimenopause and menopause. She addresses hormonal changes, metabolic shifts, and related symptoms as part of a comprehensive, personalized care plan.

Dr. Sanguinetti focuses on identifying and addressing health risks before they become chronic conditions. She uses detailed labwork, body composition assessments, and clinical evaluations to guide proactive planning. Her biochemistry background strengthens her ability to interpret metabolic data and tailor preventive strategies.

Doctor profile last updated April 10, 2026